Under the new agreement, CDI now can make use of, distribute, sublicense and sell cellular products that employ the licensed technology for therapeutic use.
http://www.prweb.com/releases/2013/5/prweb10766486.htm
http://www.prweb.com/releases/2013/5/prweb10766486.htm
No comments:
Post a Comment